
Accepting New Patients
Hirsh D. Trivedi, MD
Accepting New Patients
4.7
4.7
Gender
Male
Locations
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
2
- IM Gastroenterology
- Hepatology
Programs
Cedars-Sinai clinical programs this provider is part of:
4
Research Areas
Titles
- Chief Gastroenterology Fellow, Beth Israel Deaconess Medical Center
Education & Training
-
Harvard T.H. Chan School of Public Health
Education - Completed 2022
-
Beth Israel Deaconess Medical Center, Harvard Medical School
Fellowship - Completed 2022
-
Beth Israel Deaconess Medical Center, Harvard Medical School
Fellowship - Completed 2021
-
Tufts University School of Medicine
Residency - Completed 2016
Achievements
-
3
Board Certifications
-
5
Awards and Honors
Board Certifications
-
General Internal Medicine
American Board of Internal Medicine
-
IM/Gastroenterology
American Board of Internal Medicine
-
Transplant Hepatology
American Board of Internal Medicine
Awards and Honors
- Dr. Ramaswamy Resident Award
- ACG Case Reports Journal - Associate Editor
- Resident Professionalism Award
- AASLD Advanced/Transplant Hepatology Award
- American Journal of Transplantation - Editorial Fellow
Publications
- Ochoa-Allemant P, Trivedi HD, Saberi B, Bonder A, Fricker ZP. Waitlist and posttransplantation outcomes of lean individuals with nonalcoholic fatty liver disease. Liver Transpl. 2022 Jun 17. PMID: 35715982.
- Trivedi HD, Lopes EW, Glissen Brown J, Dudani S, Lai M, Feuerstein JD, Pierce TT. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta analysis. J Clin Gastroenterol. 2022 Jun 1. PMID: 356489
- Ferrigno B, Barba R, Medina-Morales E, Trivedi H, Patwardhan V, Bonder A. Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Feb 18;11(4):1068. PMID: 35207342; PMCID: PMC8875982
- Niezen S, Tapper EB, Trivedi H, Lai M, Curry MP, Mukamal KJ, Jiang ZG. Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA-2B Score Among US Adults. Hepatol Commun. 2021 Oct 25. PMID: 34697916.
- Dokmak A, Trivedi HD, Bonder A, Wolf J. Pregnancy in Chronic Liver Disease: Before and After Transplantation. Ann Hepatol. 2021 Dec;26:100557. Epub 2021 Oct 14. PMID: 34656772.
- Trivedi HD, Niezen S, Jiang ZG, Tapper EB. Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis. Dig Dis Sci. 2021 Aug 21. PMID: 34417922.
- Nsubuga JP, Goyes D, Trivedi HD, Medina-Morales E, Patwardhan V, Bonder A. Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases. Journal of Transplantation, vol. 2021, Article ID 6692049, 2021.
- Niezen S, Trivedi HD, Mukamal KJ, Jiang ZG. Associations between alcohol consumption and hepatic steatosis in the United States. Liver Int. 2021 Jul 23. PMID: 34297882.
- Trivedi HD, Danford CJ, Iriana S, Ochoa-Allemant P, Rourke M, Yang KC, Curry MP, Lai M. Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease sodium alone to predict mortality and liver transplantation. Eur J Gastroenterol Hepatol. 2021 Jul 6. PMID: 34231523.
- Trivedi HD, Wilechansky R, Goyes D, Vieira Barbosa J, Canakis A, Lai M, Long MT, Fricker Z. Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID 19. Gastroenterology Res. 2021 Jun;14(3):179-183. Epub 2021 Jun 19. PMID: 34267833; PMCID: PMC8256898.
- Goyes D, Trivedi HD. Upper Gastrointestinal Bleeding: A Potential Precursor to Bouveret's Syndrome. Cureus. 2021 Apr 8;13(4):e14368. PMID: 33976990; PMCID: PMC8106460
- Trivedi HD, Suri J, Oh D, Schwartz J, Goyes D, Idriss R, Curry MP, Lai M. The Presence of Diabetes Impacts Liver Fibrosis and Steatosis by Transient Elastography in a Primary Care Population. Ann Hepatol. 2021 Feb 26. PMID: 33647502.
- Campbell KA, Trivedi HD, Chopra S. Infections in cirrhosis – A guide for the clinician. Am J Med. 2021 Feb 16. PMID: 33607090.
- Dokmak A, Lizaola-Mayo B, Trivedi HD. The Impact of Non-alcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective. Am J Med. 2020 Sep 12:S0002-9343(20)30782-8. PMID: 32931760
- Efe C, Torgutalp M, Henriksson I, Alalkim F, Lytvyak E, Trivedi H, et al. Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome. J Gastroenterol Hepatol. 2020 Aug 13. PMID: 32790935.
- Trivedi HD, Ezaz G, Connelly MA, Filozof C, Howard K, Parrish ML, Kim M, Herman MA, Nasser I, Afdhal N, Jiang ZG, Lai M. Differential Associations of Circulating MicroRNAs with Pathogenic Factors in NAFLD. Hepatology Communications. 2020 March. PMID: 32363318
- Trivedi HD, Danford CJ, Goyes D, Bonder A. Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges. Clin Exp Gastroenterol. 2020, 13:17-24. PMID: 32021374
- Danford CJ, Goyes D, Trivedi HD, Bonder A. Diagnosis and treatment of gastroparesis in cirrhotic patients. NeuroGastroLatam Rev. 2019; 3(2): 77-91
- Ochoa-Allemant P, Ezaz G, Trivedi HD, Sanchez-Fernandez L, Bonder A. Long-term outcomes after liver transplantation in the Hispanic population. Liver Int. 2019 Sep 10. PMID: 31505081.
- Dokmak A, Almeqdadi M, Trivedi H, Krishnan S. Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease. World J Hepatol. 2019 Jul 27; 11(7):562-573. PMID: 31388398.
- Efe C, Tasçilar K, Henriksson I, Lytvyak E, Alalkim F, Trivedi H, et al. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis. Am J Gastroenterol. 2019 Jul; 114(7):1101-1108. PMID: 31241547.
- Danford CJ, Ezaz G, Trivedi HD, Tapper EB, Bonder A. The Pharmacologic Management of Osteoporosis in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. J Clin Densitom. 2019 May 10. PMID: 31146965
- Danford CJ, Trivedi HD, Bonder A. Bone Health in Patients With Liver Diseases. J Clin Densitom. 2019 Jan 18. PMID: 30744928
- Lee JY, Danford CJ, Trivedi HD, Tapper EB, Patwardhan VR, Bonder A. Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2019 Aug; 64(8):2338-2350. PMID: 30632051.
- Trivedi HD, Patwardhan VR, Malik R. Chronic hepatitis C infection - Noninvasive assessment of liver fibrosis in the era of direct acting antivirals. Dig Liver Dis. 2019 02; 51(2):183-189. PMID: 30553749.
- Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A. Osteoporosis in primary biliary cholangitis. World J Gastroenterol. 2018 Aug 21; 24(31):3513-3520. PMID: 30131657.
- Ortiz GA, Trivedi HD, Nader C. Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation. Hemodial Int. 2018 Apr; 22 Suppl 1:S22-S35. PMID: 29694720
- Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterol Rep (Oxf). 2018 Feb; 6(1):13-20. PMID: 29479438.
- Trivedi HD, Lin SC, T Y Lau D. Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders. Gastroenterol Hepatol (N Y). 2017 Oct; 13(10):587-595. PMID: 29391861
- Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther. 2017 Nov; 46(9):816-824. PMID: 28892178.
- Trivedi HD, Flores B, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci. 2017 May;3(3):10.15761/JTS.1000182. PMID: 30221012; PMCID: PMC6136435.
- Trivedi HD, Lizaola B, Tapper EB, Bonder A. Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review. Am J Med. 2017 Jun; 130(6):744.e1-744.e7. PMID: 28238692.
- Trivedi HD, Lizaola B, Tapper EB, Bonder A. Primary biliary cholangitis: new treatments for an old disease. Frontline Gastroenterol. 2017 Jan; 8(1):29-36. PMID: 28839882
Insurances
Before scheduling, we recommend checking with your insurance plan to see if an authorization is required to see this doctor. Primary Care Physicians (adult and pediatrics) do not require prior approval.